Global Mesna Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mesna Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Mesna injection is indicated for the prevention of urinary tract toxicity caused by oxazaphosphrine drugs (including ifosfamide, cyclophosphamide, and trophasfamide). Mesna should be used concomitantly with ifosfamide in the chemotherapy of tumors. When high-dose cyclophosphamide (greater than 10 mg/kg) and trophasfamide are used, mesna should be used in combination.
Mesna Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mesna Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mesna Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mesna Injection key manufacturers include Baxter, Cadila Healthcare, Mylan, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma, Sagent Pharmaceuticals and Athenex, etc. Baxter, Cadila Healthcare, Mylan are top 3 players and held % sales share in total in 2022.
Mesna Injection can be divided into High Dose and Low Dose, etc. High Dose is the mainstream product in the market, accounting for % sales share globally in 2022.
Mesna Injection is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Mesna Injection industry development. In 2022, global % sales of Mesna Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mesna Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Baxter
Cadila Healthcare
Mylan
Teva Pharmaceutical
Fresenius Kabi
Hikma Pharmaceuticals
Gland Pharma
Sagent Pharmaceuticals
Athenex
Jiangsu Hengrui Medicine
Sinopharm A-Think Pharmaceutical
Segment by Type
High Dose
Low Dose
Hospital
Pharmacy
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Mesna Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mesna Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mesna Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Mesna Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mesna Injection introduction, etc. Mesna Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Mesna Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Mesna Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mesna Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mesna Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mesna Injection key manufacturers include Baxter, Cadila Healthcare, Mylan, Teva Pharmaceutical, Fresenius Kabi, Hikma Pharmaceuticals, Gland Pharma, Sagent Pharmaceuticals and Athenex, etc. Baxter, Cadila Healthcare, Mylan are top 3 players and held % sales share in total in 2022.
Mesna Injection can be divided into High Dose and Low Dose, etc. High Dose is the mainstream product in the market, accounting for % sales share globally in 2022.
Mesna Injection is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Mesna Injection industry development. In 2022, global % sales of Mesna Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mesna Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Baxter
Cadila Healthcare
Mylan
Teva Pharmaceutical
Fresenius Kabi
Hikma Pharmaceuticals
Gland Pharma
Sagent Pharmaceuticals
Athenex
Jiangsu Hengrui Medicine
Sinopharm A-Think Pharmaceutical
Segment by Type
High Dose
Low Dose
Segment by Application
Hospital
Pharmacy
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Mesna Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mesna Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mesna Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Mesna Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mesna Injection introduction, etc. Mesna Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Mesna Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.